Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Genocea Closes Shop, Delists From NASDAQ

  • Genocea Biosciences Inc's (NASDAQ:GNCA) board has voted to wind down the company's ongoing operations and terminate the remaining employees except those deemed necessary to complete an orderly wind down.
  • Yesterday, the company delivered formal notice to The Nasdaq Stock Market Inc of its intent to delist voluntarily and its plans to file a Form 25 with the SEC by June 2 to effect the voluntary delisting.
  • The company received a letter that it was not in compliance with the requirement of the Nasdaq listing.
  • Also See: Genocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor Patients.
  • Last month, Genocea Biosciences initiated a process to explore a range of strategic alternatives and has engaged an investment bank to act as a strategic advisor for this process. 
  • It announced to cut its workforce by approximately 65%. In light of these developments, the company said it is reviewing its clinical and research programs to determine an appropriate course of action.
  • Price Action: GNCA shares are down 68% at $0.07 during the premarket session on the last check Tuesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.